Early Catheter-directed Treatment of High Risk Pulmonary Embolism
ConditionPulmonary Embolism Acute Massive
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorLeipzig Heart Science gGmbH
About this trial
Prospective, multicenter, open label, randomized controlled clinical trial to compare the effects of an early catheter-directed treatment plus conventional care with conventional care in patients with high-risk pulmonary embolism
Eligibility criteria
Qualifiers
Age ≥18 years
Disqualifiers
Contraindications for catheter-based treatment
Contraindications to systemic fibrinolytic treatment or anticoagulation*
Active, potentially life-threatening bleeding
Surgery within 24h before screening
Trial design
Treatments tested in this trial
- Early Catheter-Interventional Treatment
- Conventional care
Treatment groups
210 Participants
are divided into 2 treatment groupsSponsors and collaborators
Leipzig Heart Science gGmbH
Lead sponsor
Heart Center Leipzig at University of Leipzig
Collaborator
Helios Health Institute GmbH
Collaborator
Source ClinicalTrials.gov